Contact
Please use this form to send email to PR contact of this press release:
Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 3L+ mCRC
TO:
Please use this form to send email to PR contact of this press release:
Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 3L+ mCRC
TO: